世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000037305

心不全POCおよびLOCデバイス市場-予測 2022-2032

Fatpos Global

Heart Failure POC & LOC Devices Market - Regional Forecasts, 2022-2032

発刊日 2024/01

言語英語

体裁Word-PDF

ライセンス/価格

0000037305

Excel
Single
Multi
Global

※170-350ページ
※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

心不全POCおよびLOCデバイスの市場規模、シェア、分析:検査タイプ別(プロテオミクス検査、メタボロミクス検査、ゲノム検査)、技術別(マイクロ流体工学、アレイベースシステム、その他)、エンドユーザー別(クリニック、病院、家庭) 、生活支援医療施設、研究室) および地域予測、2022 〜 2032

市場概要

心不全POCおよびLOCデバイス市場は3億6,010万米ドルに達すると予想されており、デバイスの小型化、LOC(ラボオンチップ)技術によって心不全の診断を強化する大きな可能性を示し、予測期間中に16.7%のCAGRで成長する見込みです。スループット、費用対効果、分析、操作の容易さの観点から、疾患を軽減します。研究開発は、心血管疾患(CVD)の診断のための新しいLOCベースのアッセイの作成に取り組む一方で、将来の心不全POCおよびLOCデバイス市場の成長を加速すると予想されます。

レポート詳細

目次

Table of Content

1. Executive Summary
1.1. Regional Market Share
1.2. Business Trends
1.3. Heart Failure POC & LOC Devices Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot

2. Research Methodology
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation

3. Market Characteristics
3.1. Market Definition
3.2. Heart Failure POC & LOC Devices Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data

4. Heart Failure POC & LOC Devices Market - Industry Insights
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability

5. Macroeconomic Indicators

6. Recent Developments

7. Market Dynamics
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends

8. Market Analysis
8.1. Porters Five Forces
8.2. PEST Analysis
8.2.1. Political
8.2.2. Economic
8.2.3. Social
8.2.4. Technological

9. Heart Failure POC & LOC Devices Market
9.1. Overview
9.2. Historical Analysis (2016-2021)
9.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast

10. Heart Failure POC & LOC Devices Market Size & Forecast 2022A-2032F
10.1. Overview
10.2. Key Findings
10.3. Market Segmentation
10.3.1. By Test Type
10.3.1.1. Proteomic Testing
10.3.1.1.1. By Value (USD Million) 2022-2032F
10.3.1.1.2. Market Share (%) 2022-2032F
10.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.1.2. Metabolomic Testing
10.3.1.2.1. By Value (USD Million) 2022-2032F
10.3.1.2.2. Market Share (%) 2022-2032F
10.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
10.3.1.3. Genomic Testing
10.3.1.3.1. By Value (USD Million) 2022-2032F
10.3.1.3.2. Market Share (%) 2022-2032F
10.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
10.3.2. By Technology
10.3.2.1. Microfluidics
10.3.2.1.1. By Value (USD Million) 2022-2032F
10.3.2.1.2. Market Share (%) 2022-2032F
10.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.2. Array-Based Systems
10.3.2.2.1. By Value (USD Million) 2022-2032F
10.3.2.2.2. Market Share (%) 2022-2032F
10.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.3. Others
10.3.2.3.1. By Value (USD Million) 2022-2032F
10.3.2.3.2. Market Share (%) 2022-2032F
10.3.2.3.3. Y-o-Y Growth (%) 2022-2032F
10.3.3. By End User
10.3.3.1. Clinics
10.3.3.1.1. By Value (USD Million) 2022-2032F
10.3.3.1.2. Market Share (%) 2022-2032F
10.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.3.2. Hospitals
10.3.3.2.1. By Value (USD Million) 2022-2032F
10.3.3.2.2. Market Share (%) 2022-2032F
10.3.3.2.3. Y-o-Y Growth (%) 2022-2032F
10.3.3.3. Home
10.3.3.3.1. By Value (USD Million) 2022-2032F
10.3.3.3.2. Market Share (%) 2022-2032F
10.3.3.3.3. Y-o-Y Growth (%) 2022-2032F
10.3.3.4. Assisted Living Healthcare Facilities
10.3.3.4.1. By Value (USD Million) 2022-2032F
10.3.3.4.2. Market Share (%) 2022-2032F
10.3.3.4.3. Y-o-Y Growth (%) 2022-2032F
10.3.3.5. Laboratory
10.3.3.5.1. By Value (USD Million) 2022-2032F
10.3.3.5.2. Market Share (%) 2022-2032F
10.3.3.5.3. Y-o-Y Growth (%) 2022-2032F

11. North America Heart Failure POC & LOC Devices Market Size & Forecast 2022A-2032F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Test Type
11.3.2. By Technology
11.3.3. By End User
11.4. Country
11.4.1. United States
11.4.2. Canada

12. Europe Heart Failure POC & LOC Devices Market Size & Forecast 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Test Type
12.3.2. By Technology
12.3.3. By End User
12.4. Country
12.4.1. Germany
12.4.2. United Kingdom
12.4.3. France
12.4.4. Italy
12.4.5. Spain
12.4.6. Russia
12.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)

13. Asia Heart Failure POC & LOC Devices Market Size & Forecast 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Test Type
13.3.2. By Technology
13.3.3. By End User
13.4. Country
13.4.1. India
13.4.2. China
13.4.3. South Korea
13.4.4. Japan
13.4.5. Rest of APAC

14. Middle East and Africa Heart Failure POC & LOC Devices Market Size & Forecast 2022A-2032F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Test Type
14.3.2. By Technology
14.3.3. By End User
14.4. Country
14.4.1. Israel
14.4.2. GCC
14.4.3. North Africa
14.4.4. South Africa
14.4.5. Rest of Middle East and Africa

15. Latin America Heart Failure POC & LOC Devices Market Size & Forecast 2022A-2032F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Test Type
15.3.2. By Technology
15.3.3. By End User
15.4. Country
15.4.1. Mexico
15.4.2. Brazil
15.4.3. Rest of Latin America

16. Competitive Landscape
16.1. Company market share, 2021
16.2. Key player overview
16.3. Key stakeholders

17. Company Profiles
17.1. Abbott
17.1.1. Company Overview
17.1.2. Financial Overview
17.1.3. Key Product; Analysis
17.1.4. Company Assessment
17.1.4.1. Product Portfolio
17.1.4.2. Key Clients
17.1.4.3. Market Share
17.1.4.4. Recent News & Development (Last 3 Yrs.)
17.1.4.5. Executive Team
17.2. Siemens Healthineers
17.3. Roche Diagnostics USA
17.4. bioMérieux S. A
17.5. Quidel Corporation
17.6. Trinity BiotechInstrumentation Laboratory
17.7. Butterfly Network
17.8. Jant Pharmacal Corporation
17.9. Other Prominent Players

18. Appendix

19. Consultant Recommendation

この商品のレポートナンバー

0000037305

TOP